A double-blind intervention trial in healthy women demonstrates the beneficial impact on Bifidobacterium with low dosages of prebiotic galacto-oligosaccharides
Daily consumption of a low dose of GOS can lead to an increase in the relative abundance of <i>Bifidobacterium</i> in feces of healthy women. Additionally, with 2.0 g GOS, the enrichment of <i>Bifidobacterium</i> is accompanied with a shift in the overall microbiota composition.<b>Clinical trial registration</b>: clinicaltrials.gov, identifier NCT05762965.
Authors
- Maartje van den Belt (ORCID: https://orcid.org/0000-0002-9679-6925)
- Guus A. M. Kortman (ORCID: https://orcid.org/0000-0002-8076-0661)
- Eric R. Hester (ORCID: https://orcid.org/0000-0002-5232-5574)
- Arjen Nauta (ORCID: https://orcid.org/0000-0002-7150-6688)
- Marieke H. Schoemaker (ORCID: https://orcid.org/0000-0002-1806-6919)
- Ellen Looijesteijn (ORCID: https://orcid.org/0000-0002-7000-3528)
- Mirre Viskaal-van Dongen
Institutions
- FrieslandCampina (Netherlands) (NL)
- Wageningen University & Research (NL)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2024-08-19
- DOI
- https://doi.org/10.3389/fnut.2024.1440319
- Citations
- 8
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- FrieslandCampina